BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260914T080000
DTEND;TZID=America/New_York:20260914T093000
DTSTAMP:20260912T172337
CREATED:20260827T190849Z
LAST-MODIFIED:20260911T200409Z
UID:3364-1789372800-1789378200@lifescievents.com
SUMMARY:Corbus Pharmaceuticals Conference Call to Discuss Topline Data from CANYON‑1 Clinical Trial and the Potential of CRB‑913 in Obesity
DESCRIPTION:Join Corbus Pharmaceuticals for a conference call to discuss topline data for CANYON‑1\, a Phase 1b study of CRB‑913 for the treatment of obesity. The event will feature Harold Bays\, MD\, an investigator of the study. \nThe Company will provide an overview of CRB‑913\, a once-daily highly peripherally restricted oral CB1 inverse agonist potentially offering an orthogonal approach to weight loss and long-term weight management and a new therapeutic option for obesity beyond GLP‑1 and other incretin-targeting therapies. Management will also review the CANYON‑1 Phase 1b clinical trial\, a 16‑week double-blind\, placebo-controlled\, dose-ranging study in 240 obese\, non-diabetic adult participants conducted at multiple clinical sites in the United States (NCT07310901). \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/cku39pl/.
URL:https://lifescievents.com/event/cku39pl/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/08/Events-Banners_2-10.png
END:VEVENT
END:VCALENDAR